EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access

Combined Gastric Electrical Stimulation and Pyloroplasty in Gastroparesis

Irene Sarosiek, Mohammad Bashashati, Brian R Davis, Karina Espino, Denise Vasquez, Ryan Torelli, Tamis Bright, Jerzy Sarosiek, Jesus R Diaz, Osvaldo Padilla, Alok K Dwivedi, Richard W McCallum

JAMA Network Open · 2025

DOI: 10.1001/jamanetworkopen.2025.46332 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift JAMA Network Open, 2025. Verfasst von Irene Sarosiek und 11 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology, Department of Medicine, Texas Tech University Health Sciences Center, El Paso. Hauptthemen laut MEDLINE: Gastroparesis, Electric Stimulation Therapy, Pyloromyotomy. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Importance Patients with gastroparesis who do not respond to medical therapy may require surgical intervention, typically involving pyloroplasty (PP) alone or with implantation of a gastric electrical stimulation (GES) device.

Objective

To investigate the outcomes of combining PP with GES in medication-refractory gastroparesis. Design, Setting, and Participants This double-blind randomized clinical trial included patients who had diabetic or idiopathic gastroparesis. Patients from a US academic gastrointestinal motility clinic, who failed medical therapy, were included from January 10, 2017, to September 20, 2023. Patients were followed up for 6 months.

Interventions

Patients with refractory gastroparesis underwent simultaneous implantation of GES with PP and were randomized into PP + GES-ON and PP + GES-OFF groups. In the PP + GES-ON group, the GES was turned on after surgery. In the PP + GES-OFF group, the device was kept off for 3 months and then was turned on for the following 3 months. Main Outcomes and Measures Symptom scores measured with the Gastroparesis Cardinal Symptom Index (GCSI) and the total symptom score (TSS), gastric emptying, and hospitalization length of stay were recorded and compared at baseline and at 3-month and 6-month follow-up visits. Between-group comparisons at 3 months were performed using the Wilcoxon rank sum test following the intention-to-treat procedure.

Results

The study included 38 patients with gastroparesis (24 females [63.2%]; mean [SD] age, 46.7 [13.2] years), of whom 31 (81.6%) had diabetic gastroparesis, and 7 (18.4%) had idiopathic gastroparesis. Patients were randomized to the PP + GES-ON (n = 19) or the PP + GES-OFF (n = 19) group. At 3 months, the improvement from baseline in the GCSI (median [IQR] ON: −2.2 [−2.6 to −1.5] vs median [IQR] OFF: −0.9 [−1.8 to −0.4]; median difference, −1.33 [95% CI, −2.34 to −0.33]; P = .01) and the TSS (median [IQR] ON: −15.0 [−16.0 to −8.0] vs median [IQR] OFF: −3.0 [−10.0 to −1.0]; median difference, −12.00 [95% CI, −17.49 to −6.51]; P = .005) was significantly greater in the PP + GES-ON compared with the PP + GES-OFF group. Both groups exhibited significantly faster and similar gastric emptying results compared with the baseline. When the PP + GES-OFF group had GES activated at 3 months, symptoms improved significantly by 6 months (median [IQR] GCSI at 6 months: 1.2 [0.4-2.5] vs at baseline: 3.3 [2.8-4.1]; median [IQR] TSS at 6 months: 8.0 [2.0-10.0] vs at baseline: 18 [14.0-21.0]), achieving results comparable with those patients who had their GES device on for the full 6 months. These results at 6 months were accompanied by a significant reduction in hospital length of stay (median [IQR] at 6 months: 0 [0-2.0] vs at baseline: 4.1 [0-10.1]) and an excellent safety profile. Conclusions and Relevance In this randomized clinical trial, the combination of GES and PP yielded superior outcomes compared with PP alone, resulting in greater alleviation of gastroparesis symptoms and a reduction in hospitalization, which may enhance patient profiling and optimize decision-making for treatments. Trial Registration ClinicalTrials.gov Identifier: NCT03123809

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GastroparesisElectric Stimulation TherapyPyloromyotomyHumansFemaleMaleMiddle AgedDouble-Blind MethodAdultTreatment OutcomeGastric EmptyingCombined Modality Therapy

Autor:innen und Institutionen

  • Division of Gastroenterology, Department of Medicine, Texas Tech University Health Sciences Center, El Paso.
  • Division of Gastroenterology, Department of Medicine, Dell Medical School, The University of Texas at Austin.
  • Christus Trinity Clinic, Corpus Christi, Texas.
  • Paul L. Foster School of Medicine, Texas Tech University Health Sciences Center, El Paso.
  • Division of Endocrinology, Department of Medicine, Texas Tech University Health Sciences Center, El Paso.
  • Department of Radiology, Texas Tech University Health Sciences Center, El Paso.

Zitieren

APA

Sarosiek, I., Bashashati, M., Davis, B. R., Espino, K., Vasquez, D., Torelli, R., Bright, T., Sarosiek, J., Diaz, J. R., Padilla, O., Dwivedi, A. K., & McCallum, R. W. (2025). Combined Gastric Electrical Stimulation and Pyloroplasty in Gastroparesis. JAMA Network Open. https://doi.org/10.1001/jamanetworkopen.2025.46332

Vancouver

Sarosiek I, Bashashati M, Davis BR, Espino K, Vasquez D, Torelli R, et al. Combined Gastric Electrical Stimulation and Pyloroplasty in Gastroparesis. JAMA Network Open. 2025. doi:10.1001/jamanetworkopen.2025.46332

BibTeX
@article{Sarosiek2025,
  author = {Sarosiek, Irene and Bashashati, Mohammad and Davis, Brian R and Espino, Karina and Vasquez, Denise and Torelli, Ryan and Bright, Tamis and Sarosiek, Jerzy and Diaz, Jesus R and Padilla, Osvaldo and Dwivedi, Alok K and McCallum, Richard W},
  title = {Combined Gastric Electrical Stimulation and Pyloroplasty in Gastroparesis},
  journal = {JAMA Network Open},
  year = {2025},
  doi = {10.1001/jamanetworkopen.2025.46332}
}
Kostenlos starten →